- Castlight Health (NYSE:CSLT) initiated with Market Perform rating and $4 (23% upside) price target by Cowen & Co.
- CymaBay Therapeutics (NASDAQ:CBAY) upgraded to Buy by H.C. Wainwright.
- Array BioPharma (NASDAQ:ARRY) downgraded to Market Perform by Leerink Swann.
- Regulus Therapeutics (NASDAQ:RGLS) downgraded to Market Perform by Wells Fargo and Hold by Needham (shares are down 29% premarket on extension of clinical hold on RG-101 until at least Q4).
- Select Medical (NYSE:SEM) downgraded to Market Perform by Wells Fargo.